SEGMENT REPORTING (Tables)

6 Months Ended

Jun. 30, 2012

Segment Reporting [Abstract]

Schedule of certain information of these segments

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Revenues
Surgical products	$	15,922		$	15,470		$	31,416		$	29,862
Brachytherapy seed		6,315			6,278			12,635			12,231
Intersegment eliminations		(281	)		(212	)		(512	)		(304	)
	$	21,956		$	21,536		$	43,539		$	41,789
Earnings from operations
Surgical products	$	588		$	498		$	787		$	307
Brachytherapy seed		747			1,517			2,127			2,595
Intersegment eliminations		(20	)		(12	)		(23	)		(13	)
	$	1,315		$	2,003		$	2,891		$	2,889
Capital expenditures, excluding asset acquisition
Surgical products	$	411		$	503		$	683		$	1,127
Brachytherapy seed		242			105			299			177
	$	653		$	608		$	982		$	1,304
Depreciation and amortization
Surgical products	$	1,214		$	1,233		$	2,443		$	2,434
Brachytherapy seed		923			579			1,677			1,158
	$	2,137		$	1,812		$	4,120		$	3,592

Schedule of supplemental information related to significant assets

	June 30, 2012			December 31, 2011
Identifiable assets
Surgical products	$	72,646		$	72,475
Brachytherapy seed		69,522			60,791
Corporate investment in subsidiaries		111,439			111,439
Intersegment eliminations		(133,643	)		(128,887	)
	$	119,964		$	115,818
Intangible assets
Surgical products	$	8,015		$	9,404
Brachytherapy seed		8,259			55
	$	16,274		$	9,459

Schedule of information regarding revenue by geographic regions

	Three Months Ended June 30,				Six Months Ended June 30,
	2012		2011		2012		2011
Product sales
United States	$	17,876	$	18,645	$	36,824	$	35,851
Europe		2,285		2,009		3,794		4,184
Other foreign countries		1,152		314		1,674		671
		21,313		20,968		42,292		40,706
License and fee income
United States		258		222		505		419
Canada		385		346		742		664
		643		568		1,247		1,083
	$	21,956	$	21,536	$	43,539	$	41,789